APA Alıntı

Kantarjian, H., O’Brien, S., Garcia-Manero, G., Faderl, S., Ravandi, F., Jabbour, E., . . . Cortes, J. (2012). Very Long-term Follow-Up Results of Imatinib Mesylate Therapy in Chronic Phase Chronic Myeloid Leukemia After Failure of Interferon Alpha Therapy.

Chicago Stili Alıntı

Kantarjian, Hagop, Susan O’Brien, Guillermo Garcia-Manero, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Jianqin Shan, ve Jorge Cortes. Very Long-term Follow-Up Results of Imatinib Mesylate Therapy in Chronic Phase Chronic Myeloid Leukemia After Failure of Interferon Alpha Therapy. 2012.

MLA Alıntı

Kantarjian, Hagop, et al. Very Long-term Follow-Up Results of Imatinib Mesylate Therapy in Chronic Phase Chronic Myeloid Leukemia After Failure of Interferon Alpha Therapy. 2012.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..